DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

COVID-19
Adapting and innovating in a changed healthcare ecosystem

Healthcare companies are struggling to help patients impacted by pandemic disruptions, while adapting to a chaotic, fast-changing market environment.

We’ve assembled resources to help companies support their customers and plan for the post-pandemic marketplace. We’ll be updating this site with fresh content continuously as we work through this global healthcare crisis together.

Contact us for more information on how we’re helping life science companies adapt to this global health crisis.

White Paper
Mitigating COVID-19-related healthcare disruption
Adapting to a post-pandemic environment

Dashboard
Interactive Dashboard - COVID-19 Real World Data and Insights

Video
Utilizing pluripotent stem cells in cell therapy with Brian Culley, CEO Lineage Cell Therapeutics
Video
Pivoting a product launch during the pandemic with Bryan Witherbee, President and CEO, Adarza BioSystems
Video
Possible treatment for COVID-19 related respiratory failure with Jonathan C. Javitt, CEO, NeuroRx
Video
Transforming the treatment of cancer with oncolytic viruses with Stephen J. Russell, CEO, Vyriad
Video
Early planning key to successful access and product launch with Alison Kneen, Senior Vice President, Decision Resources Group
Video
COVID-19, multi-stem clinical trials and a new way of fundraising with Gil Van Bokkelen, Founder, Chairman and CEO at Athersys Inc.
Video
Maximising R+D efforts through better epidemiology understanding with Mike Hughes, Senior Director of Epidemiology, DRG
Video
Addressing strategic challenges for biotech companies with Dr Srikanth Rajagopal, Consulting Partner, DRG
Video
Bringing together minds to combat COVID-19 with Sir Mene Pangalos, Executive Vice President, AstraZeneca
Video
An unprecedented time of scientific innovation with Houman Ashrafian, Managing Partner, SV Health Investors
Video
Securing investments amidst COVID-19 and Brexit uncertainties with Hakan Goker, Vice President, M Ventures
Video
The advantages of onsite manufacturing facilities for clinical trials with Bill Newell, CEO, Sutro Biopharma
Video
Bringing new medicines to market despite subjective endpoints with Seth Lederman, CEO & Chairman, Tonix Pharmaceuticals
Video
Revolutionising the neurodegenerative space – fundraising, development & beyond with Sanjay Kakkar, CEO, Tranquis Therapeutics

EBOOK
Impact of COVID-19 on Elective & Non-Essential Procedures

EXECUTIVE BRIEF
COVID-19 Market Impact Assessments

Video
How COVID is reshaping global policy and what it means for market access with Steve Edgar and Judith Rubinstein, DRG market access experts

Video
Will healthcare change after COVID-19 with Richard Erwin, General Manager and Managing Director, Roche Products Ltd (UK)

Video
Becoming one of the leaders in developing COVID-19 diagnostics with Mark Stevenson, Vice President and Chief Operation Officer, Thermo Fisher Scientific

Video
Using a problem centric approach to build programs with Eric Elenko, Chief Innovation Officer, PureTech

Video
How innovation can continue to evolve and shape the pharma space with Daphne Zohar, Founder & CEO, PureTech

Video
The pandemic, politicians and science with Baroness Susan Greenfield, Founder & CEO, Neuro-Bio

Video
How China has grown through innovation to rival the US market with Christian Hogg, CEO and Executive Director, Chi-Med

Video
Physicians find new ways to share best practice - with Mike Clayman, CEO and Co-Founder, Flexion Therapeutics

Article
How global health supply chain shifts may change manufacturing

Article
How renewed emphasis on novel disease testing may increase RWE-reliance

Article
How streamlined regulatory processes may speed time to market for novel treatments

Article
How HTA delays may impact non-COVID-19-related conditions

Article
How global health systems are thinking outside the box for access and delivery

Executive Brief
How COVID-19 is reshaping global policy and what it means for market access

Infographic
Growing telemedicine adoption in EU5 markets

Video
The effects of COVID-19 on worldwide oncology clinical trials - with Steve Fruchtman, Onconova Therapeutics Inc

Video
COVID-19 continues to disrupt patient care - with John Jaeger, Decision Resources Group

Video
To know COVID-19 is to know medicine - with Dr. RJ Tesi, INmune Bio

Video
Impact of COVID-19 on the development of CAR T-cell therapies - with Dana Gheorghe, Decision Resources Group

Video
Wuhan experience shapes the new normal for healthcare – with Christian Hogg, Hutchison China MediTech

Video
Creating a collaborative toolbox to fight COVID-19 – with Dr. Werner Lanthaler, Evotec

Article
COVID-19 complicates value-based care

Article
Diagnosing the state of COVID-19 testing

Infographic
Engaging HCPs as medical conferences move online

Infographic
How COVID-19 is transforming telemedicine

Article
How COVID-19 is bringing seismic shifts to healthcare delivery

Article
Ongoing coverage of the development of drugs, vaccines and diagnostics

Article
The next pandemic

Executive Brief
Specialists confront new barriers to care and treatment

Article
How providers are addressing patient and HCP mental health

Article
The hard questions life science orgs are asking

Resource Hub
Hosptial best practices and tools

Article
Devices and diagnostics: pandemic impacts

Clarivate clinical research and news

Are you a DRG customer?
Additional COVID-19 data and insights included in your subscriptions

Contact us for more information on how we’re helping life science companies adapt to this global health crisis.

Note: For informational purposes only; DRG does not provide clinical or legal advice. For additional guidance and information, please consult public health agencies such as the CDC and World Health Organization.